arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Xtant Medical Holdings, Inc.

XTNT
$0.30 0.00 (+1.04%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Xtant Medical Holdings, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $42.1M
Dividend Yield —
Revenue Growth -35.0% ↗
Op. Margin -39.8% ↘
ROIC -19.5% ↘
FCF / Share $-0.05 ↘
Trailing P/E —
Price / Book 1.1x
FCF Yield —
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Nov 5, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$23.03M
↓ -35.0% —
Net Income Profit after all expenses
$-3.09M
— 0.0% —
Operating Margin Operating profit as % of sales
-39.8%
↓ -184.4% 44th
FCF / Share Free cash flow per share
$-0.05
↓ -226.9% —
Long-Term Debt Long-term obligations
$7.29M
↓ -10.0% —

Health Breakdown

Profitability
47
Returns
67
Financial Health ↓
65
Cash Quality ↑
86

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 17 years · 67 quarters